I've read many posts over the last week or so and have
I've read many posts over the last week or so and have stayed rather quiet.
I just want to point out that if you are truly investing in FITX for the future and
are really LONG this company then the timing of this license only matters
for when we will be able to start growing.
I look at these times to accumulate more here where I thought we would be
paying a much higher premium by now, call me silly but I for one am happy
to be able to accumulate even more at these prices. The only ones real
concerned about timing are those that TRADE this frequently and are upset
to have funds tied longer than they wanted IMO.
I'm looking longer term and down the road myself because I have no doubt
we will be a very LARGE company and presence in the MJ and HEMP arena.
So whether it's June, July or August doesn't stop where this company is
headed and a year from now this company will have a PPS that has
appreciated to the scale of operations and revenues... which I believe will
be very substantial and will have a whole new level of investors.
If you believe in the company like I do, the day to day should only looked at
you strengthen your overall position.
Creative Edge Nutrition Inc. (FITX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Nvidia Invests $500 Million in Wayve Nvidia, known for its advanced AI technologies, is in discussions to invest a substantial $500 million into the U.K.-based autonomous driving startup Wayve. This move marks a significant step for Nvidia as it seeks to deepen its involvement in the rapidly evolving artificial intelligence sector. Strategic Importance of the Investment...
Continue Reading
Elevating Leadership at Vortex Companies Vortex Companies, known for its rapid growth in the trenchless infrastructure rehabilitation sector, has recently made significant leadership changes with the promotions of Jonathan Thomas and Connor Mathis. Thomas steps into the role of Senior Regional Vice President for the Coastal Region, while Mathis ascends to Regional Vice...
Continue Reading
Scilex Holding Company’s FDA Milestone with ELYXYB Scilex Holding Company, based in Palo Alto, California, has gained significant recognition with the U.S. FDA's acknowledgment of their Supplemental New Drug Application (SNDA) for ELYXYB. This marks a substantial step forward for the company, which is dedicated to creating and advancing non-opioid pain management...
Continue Reading
Advanced Proteins in the Spotlight Bio-Techne’s latest move is creating some serious buzz in the life sciences scene. They're not just talking the talk but walking the walk by expanding their R&D Systems AI-Engineered Designer Protein portfolio. What's the big news? They've engineered heat-stable and hyperactive proteins that promise to shake up fibroblast growth factor...
Continue Reading
Groundbreaking Advances in Surgical Infection Prevention PolyPid Ltd. has made headlines recently, unveiling remarkable topline results from their pivotal SHIELD II Phase 3 trial. This innovative study showcased D-PLEX100, a major breakthrough in preventing surgical site infections (SSIs), showing statistically significant reductions in both primary and secondary...
Continue Reading